1. Home
  2. EVOK vs NURO Comparison

EVOK vs NURO Comparison

Compare EVOK & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • NURO
  • Stock Information
  • Founded
  • EVOK 2007
  • NURO 1996
  • Country
  • EVOK United States
  • NURO United States
  • Employees
  • EVOK N/A
  • NURO N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • NURO Medical/Dental Instruments
  • Sector
  • EVOK Health Care
  • NURO Health Care
  • Exchange
  • EVOK Nasdaq
  • NURO Nasdaq
  • Market Cap
  • EVOK 7.1M
  • NURO 8.2M
  • IPO Year
  • EVOK 2013
  • NURO N/A
  • Fundamental
  • Price
  • EVOK $5.37
  • NURO $4.38
  • Analyst Decision
  • EVOK
  • NURO
  • Analyst Count
  • EVOK 0
  • NURO 0
  • Target Price
  • EVOK N/A
  • NURO N/A
  • AVG Volume (30 Days)
  • EVOK 9.0K
  • NURO 19.9K
  • Earning Date
  • EVOK 03-13-2025
  • NURO 02-24-2025
  • Dividend Yield
  • EVOK N/A
  • NURO N/A
  • EPS Growth
  • EVOK N/A
  • NURO N/A
  • EPS
  • EVOK N/A
  • NURO N/A
  • Revenue
  • EVOK $8,617,036.00
  • NURO $3,767,764.00
  • Revenue This Year
  • EVOK $97.35
  • NURO N/A
  • Revenue Next Year
  • EVOK $99.52
  • NURO N/A
  • P/E Ratio
  • EVOK N/A
  • NURO N/A
  • Revenue Growth
  • EVOK 100.35
  • NURO N/A
  • 52 Week Low
  • EVOK $3.54
  • NURO $2.66
  • 52 Week High
  • EVOK $12.32
  • NURO $4.73
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 65.36
  • NURO 67.35
  • Support Level
  • EVOK $4.68
  • NURO $4.16
  • Resistance Level
  • EVOK $5.40
  • NURO $4.39
  • Average True Range (ATR)
  • EVOK 0.33
  • NURO 0.06
  • MACD
  • EVOK 0.07
  • NURO 0.00
  • Stochastic Oscillator
  • EVOK 97.46
  • NURO 91.56

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: